Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioAtla, Inc.BCAB · Entity 879 | Chief Financial Officer | August 31, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioAtla, Inc.
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,476 |
Reported balance
After 2026-08-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-31 · Tax withholding · Disposed 71 · Balance 10,476 F1: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2: Includes shares purchased under the Issuer's ESPP. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
F2: Includes shares purchased under the Issuer's ESPP.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 21:26 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 71 | $1.69 | $119.99 |
DisclosureSEC source: 0001193125-26-380479 · ownership.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,476 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP. Read SEC document |
| May 31, 2026 Filed Jun 5, 2026 20:30 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 82 | $3.93 | $322.26 |
DisclosureSEC source: 0001193125-26-259699 · ownership.xml · nonDerivative · entry 2 Vasquez Christian · CIK 0001835732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,347 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation. Read SEC document |
| March 11, 2026 Filed Jun 5, 2026 20:30 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 175 | $0.17 | $29.58 |
DisclosureSEC source: 0001193125-26-259699 · ownership.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,429 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:07 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-104132 · ownership.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 530,196 F1 · shares: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 10, 2027, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| February 28, 2026 Filed Mar 2, 2026 23:14 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 1,802 | $0.25 | $445.09 |
DisclosureSEC source: 0001193125-26-085970 · ownership.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,196 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| November 30, 2025 Filed Dec 1, 2025 23:34 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 1,566 | $0.90 | $1,415.66 |
DisclosureSEC source: 0001193125-25-304170 · ownership.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,998 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP. Read SEC document |
| August 31, 2025 Filed Sep 2, 2025 23:08 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 1,566 | $0.46 | $713.31 |
DisclosureSEC source: 0000950170-25-112616 · ownership.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,564 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 20:29 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 1,566 | $0.41 | $640.49 |
DisclosureSEC source: 0000950170-25-080980 · ownership.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,130 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:12 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantCommon Stock | 85,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038748 · ownership.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,696 F1 · shares: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2026, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February so long as the reporting person remains a service provider. Read SEC document |
| February 15, 2025 Filed Feb 25, 2025 01:29 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 7,189 | $0.46 | $3,306.94 |
DisclosureSEC source: 0000950170-25-025962 · ownership.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,696 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:22 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003509 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,659 F1 · shares: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on February 15, 2025, and the remainder in equal quarterly installments over the three years thereafter, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| December 19, 2023 Filed Dec 19, 2023 21:33 UTC | BioAtla, Inc. BCAB · Entity 879 | PurchaseCommon Stock | 7,495 | $2.04 | $15,262.07 |
DisclosureSEC source: 0001209191-23-059164 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,659 F1 · price: The range of prices for the shares of Common Stock is from $2.02 to $2.04. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 01:16 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $1.47 | $285.18 |
DisclosureSEC source: 0001209191-23-054061 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,162 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| September 30, 2023 Filed Oct 2, 2023 22:04 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $1.70 | $329.80 |
DisclosureSEC source: 0001209191-23-051182 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,356 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| August 31, 2023 Filed Sep 2, 2023 00:04 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $2.51 | $486.94 |
DisclosureSEC source: 0001209191-23-048034 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,550 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 21:40 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $2.99 | $580.06 |
DisclosureSEC source: 0001209191-23-044046 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,744 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 21:44 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $3.00 | $582.00 |
DisclosureSEC source: 0001209191-23-040667 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,938 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 00:23 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $3.15 | $611.10 |
DisclosureSEC source: 0001209191-23-033469 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,132 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| April 30, 2023 Filed May 2, 2023 22:00 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $3.37 | $653.78 |
DisclosureSEC source: 0001209191-23-026656 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,326 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 00:00 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 189 | $2.68 | $506.52 |
DisclosureSEC source: 0001209191-23-022426 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,520 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 28, 2023 Filed Mar 29, 2023 21:20 UTC | BioAtla, Inc. BCAB · Entity 879 | PurchaseCommon Stock | 20,000 | $2.40 | $47,970.00 |
DisclosureSEC source: 0001209191-23-021543 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,709 F1 · price: The range of prices for the shares of Common Stock is from $2.39 to $2.40. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 23:31 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 229 | $2.98 | $682.42 |
DisclosureSEC source: 0001209191-23-014290 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,709 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 09, 2023 Filed Mar 1, 2023 23:31 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantEmployee Stock Option (right to buy) · Derivative | 135,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001209191-23-014290 · doc4.xml · derivative · entry 2 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2033-02-09 F2 · derivative.exercise_date: The option vests over a period of four years, with 25% of the shares underlying the option vesting on the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service to the company through the applicable vesting dates. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 00:04 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 229 | $3.79 | $867.91 |
DisclosureSEC source: 0001209191-23-006424 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,938 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 22:02 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $8.25 | $1,600.50 |
DisclosureSEC source: 0001209191-23-000305 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,167 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 01:56 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $11.01 | $2,135.94 |
DisclosureSEC source: 0001209191-22-059263 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,361 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 23:53 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $6.89 | $1,336.66 |
DisclosureSEC source: 0001209191-22-055165 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,555 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 00:16 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $7.70 | $1,493.80 |
DisclosureSEC source: 0001209191-22-052556 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,749 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 22:51 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $8.71 | $1,689.74 |
DisclosureSEC source: 0001209191-22-048366 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,943 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| July 31, 2022 Filed Aug 1, 2022 22:27 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $3.40 | $659.60 |
DisclosureSEC source: 0001209191-22-043742 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,137 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 21:24 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $2.85 | $552.90 |
DisclosureSEC source: 0001209191-22-040325 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,331 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 20:05 UTC | BioAtla, Inc. BCAB · Entity 879 | PurchaseCommon Stock | 10,000 | $2.97 | $29,720.00 |
DisclosureSEC source: 0001209191-22-035350 · doc4.xml · nonDerivative · entry 3 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,525 F3 · price: The range of prices for the shares of Common Stock is from $2.93 to $3.00. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:05 UTC | BioAtla, Inc. BCAB · Entity 879 | PurchaseCommon Stock | 25,848 | $3.02 | $78,187.62 |
DisclosureSEC source: 0001209191-22-035350 · doc4.xml · nonDerivative · entry 2 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,525 F2 · price: The range of prices for the shares of Common Stock is from $2.98 to $3.05. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:05 UTC | BioAtla, Inc. BCAB · Entity 879 | PurchaseCommon Stock | 14,152 | $3.04 | $43,006.51 |
DisclosureSEC source: 0001209191-22-035350 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,677 F1 · price: The range of prices for the shares of Common Stock is from $2.66 to $3.10. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 22:06 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $2.41 | $467.54 |
DisclosureSEC source: 0001209191-22-034305 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,525 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| April 30, 2022 Filed May 6, 2022 20:59 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 189 | $3.48 | $657.72 |
DisclosureSEC source: 0001209191-22-027631 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,719 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 01:14 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 189 | $5.00 | $945.00 |
DisclosureSEC source: 0001209191-22-022744 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,908 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 28, 2022 Filed Mar 4, 2022 22:04 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 230 | $6.48 | $1,490.40 |
DisclosureSEC source: 0001209191-22-016374 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,097 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 21, 2022 Filed Feb 25, 2022 02:17 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantEmployee Stock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0001209191-22-012940 · doc4.xml · derivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2032-02-21 F1 · derivative.exercise_date: The option vests over a period of four years, with 25% of the shares underlying the option vesting on February 21, 2023, the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting dates. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 22:44 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 230 | $9.56 | $2,198.80 |
DisclosureSEC source: 0001209191-22-006503 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,327 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| December 31, 2021 Filed Jan 6, 2022 01:34 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 194 | $19.63 | $3,808.22 |
DisclosureSEC source: 0001209191-22-002042 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,065 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| December 02, 2021 Filed Dec 7, 2021 22:43 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 4 | $22.47 | $89.88 |
DisclosureSEC source: 0001209191-21-068387 · doc4.xml · nonDerivative · entry 8 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,259 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F9 · price: The range of prices for the shares of Common Stock is from $22.40 to $22.51. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 02, 2021 Filed Dec 7, 2021 22:43 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 196 | $21.74 | $4,261.24 |
DisclosureSEC source: 0001209191-21-068387 · doc4.xml · nonDerivative · entry 7 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,263 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F8 · price: The range of prices for the shares of Common Stock is from $21.40 to $22.37. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 01, 2021 Filed Dec 7, 2021 22:43 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 123 | $24.22 | $2,979.55 |
DisclosureSEC source: 0001209191-21-068387 · doc4.xml · nonDerivative · entry 6 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,459 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F7 · price: The range of prices for the shares of Common Stock is from $23.80 to $24.68. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 01, 2021 Filed Dec 7, 2021 22:43 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 563 | $23.27 | $13,098.76 |
DisclosureSEC source: 0001209191-21-068387 · doc4.xml · nonDerivative · entry 5 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,582 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F6 · price: The range of prices for the shares of Common Stock is from $22.79 to $23.77. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 01, 2021 Filed Dec 7, 2021 22:43 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 325 | $22.19 | $7,210.45 |
DisclosureSEC source: 0001209191-21-068387 · doc4.xml · nonDerivative · entry 4 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,145 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F5 · price: The range of prices for the shares of Common Stock is from $21.79 to $22.73. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 30, 2021 Filed Dec 7, 2021 22:43 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 118 | $25.38 | $2,994.72 |
DisclosureSEC source: 0001209191-21-068387 · doc4.xml · nonDerivative · entry 3 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,470 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F4 · price: The range of prices for the shares of Common Stock is from $25.30 to $25.38. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 30, 2021 Filed Dec 7, 2021 22:43 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 338 | $24.68 | $8,340.49 |
DisclosureSEC source: 0001209191-21-068387 · doc4.xml · nonDerivative · entry 2 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,588 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F3 · price: The range of prices for the shares of Common Stock is from $24.33 to $25.25. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 30, 2021 Filed Dec 7, 2021 22:43 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 312 | $24.00 | $7,487.06 |
DisclosureSEC source: 0001209191-21-068387 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,926 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $23.33 to $24.32. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 29, 2021 Filed Dec 7, 2021 01:43 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 642 | $23.89 | $15,337.38 |
DisclosureSEC source: 0001209191-21-068215 · doc4.xml · nonDerivative · entry 1 Vasquez Christian · CIK 0001835732 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,238 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $23.75 to $24.11. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.